Literature DB >> 1697913

A subgroup-specific antigenic site in the G protein of respiratory syncytial virus forms a disulfide-bonded loop.

B Akerlind-Stopner1, G Utter, M A Mufson, C Orvell, R A Lerner, E Norrby.   

Abstract

An antigenic site (represented by 15 amino acids, residues 174 to 188, designated peptide 12) of the large glycoprotein G of respiratory syncytial virus was demonstrated to be subgroup specific in peptide enzyme-linked immunosorbent assay tests with murine monoclonal antibodies and human postinfection sera. The role of individual amino acids in this subgroup-specific site was determined by use of single-amino-acid-deletion sets of peptides. When monoclonal antibodies were reacted with the deletion sets, a broad amino acid dependence of 11 or 12 residues, Cys-176 (Ile-175 in subgroup B) to Cys-186, was found. Human postinfection sera exhibited a narrower reaction profile (for subgroup A, Cys-182 to Trp-183; for subgroup B, Cys-176 to Lys-183). Reduction of peptides on microtiter plates by treatment with dithiothreitol completely destroyed their antigenic activity in tests with monoclonal antibodies and human postinfection sera of subgroup B. A variant of peptide 12 containing all four cysteines of the G protein (represented by 16 amino acids, residues 172 to 187, designated peptide 12var) also was subgroup specific. We concluded that the activity of the antigenic site in tests with monoclonal antibodies for subgroups A and B appears to depend on intrapeptide disulfide bonds. Reactions with postinfection sera of subgroup B also may depend on a disulfide bond. In contrast, postinfection sera of subgroup A appeared to have the capacity to identify a subgroup-specific site in a linear form of the selected 15-amino-acid-long peptide. Treatment of peptides with dithiothreitol had no effect on their antigenic activity in tests with human postinfection sera of subgroup A. These findings have relevance for molecular engineering of peptide antigens for use in respiratory syncytial virus subgroup-specific site-directed serology.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1697913      PMCID: PMC248006     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  RESPIRATORY SYNCYTIAL VIRUS: OBSERVATIONS ON ANTIGENIC HETEROGENEITY.

Authors:  H WULFF; P KIDD; H A WENNER
Journal:  Proc Soc Exp Biol Med       Date:  1964-01

2.  Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization.

Authors:  R CHANOCK; B ROIZMAN; R MYERS
Journal:  Am J Hyg       Date:  1957-11

3.  Two distinct subtypes of human respiratory syncytial virus.

Authors:  M A Mufson; C Orvell; B Rafnar; E Norrby
Journal:  J Gen Virol       Date:  1985-10       Impact factor: 3.891

4.  General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.

Authors:  R A Houghten
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

5.  The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins.

Authors:  P R Johnson; M K Spriggs; R A Olmsted; P L Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

6.  Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B.

Authors:  C Orvell; E Norrby; M A Mufson
Journal:  J Gen Virol       Date:  1987-12       Impact factor: 3.891

7.  Strategies for epitope analysis using peptide synthesis.

Authors:  H M Geysen; S J Rodda; T J Mason; G Tribbick; P G Schoofs
Journal:  J Immunol Methods       Date:  1987-09-24       Impact factor: 2.303

8.  Mapping an antibody-binding site and a T-cell-stimulating site on the 1A protein of respiratory syncytial virus.

Authors:  J A Nicholas; M A Mitchell; M E Levely; K L Rubino; J H Kinner; N K Harn; C W Smith
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

9.  Serological studies with respiratory syncytial virus.

Authors:  J E Doggett; D Taylor-Robinson
Journal:  Arch Gesamte Virusforsch       Date:  1965

10.  Respiratory syncytial virus: heterogeneity of subgroup B strains.

Authors:  B Akerlind; E Norrby; C Orvell; M A Mufson
Journal:  J Gen Virol       Date:  1988-09       Impact factor: 3.891

View more
  16 in total

1.  Effect of core epitope modification on the antibody recognition of a MUC2 mucin peptide.

Authors:  Katalin Uray; Ferenc Hudecz
Journal:  Mol Divers       Date:  2012-03-04       Impact factor: 2.943

Review 2.  Respiratory syncytial virus genetic and antigenic diversity.

Authors:  W M Sullender
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

3.  Determination of the disulfide bond arrangement of human respiratory syncytial virus attachment (G) protein by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  J J Gorman; B L Ferguson; D Speelman; J Mills
Journal:  Protein Sci       Date:  1997-06       Impact factor: 6.725

4.  A subtype-specific peptide-based enzyme immunoassay for detection of antibodies to the G protein of human respiratory syncytial virus is more sensitive than routine serological tests.

Authors:  J P Langedijk; A H Brandenburg; W G Middel; A Osterhaus; R H Meloen; J T van Oirschot
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

5.  Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein.

Authors:  H Plotnicky-Gilquin; L Goetsch; T Huss; T Champion; A Beck; J F Haeuw; T N Nguyen; J Y Bonnefoy; N Corvaïa; U F Power
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

6.  Immunodominant T-cell epitope on the F protein of respiratory syncytial virus recognized by human lymphocytes.

Authors:  M E Levely; C A Bannow; C W Smith; J A Nicholas
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

7.  Evolution of bovine respiratory syncytial virus.

Authors:  J F Valarcher; F Schelcher; H Bourhy
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

8.  Antigenic structure of the central conserved region of protein G of bovine respiratory syncytial virus.

Authors:  J P Langedijk; R H Meloen; G Taylor; J M Furze; J T van Oirschot
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

9.  Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection.

Authors:  Jae-Rang Yu; Sol Kim; Jee-Boong Lee; Jun Chang
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

10.  Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein.

Authors:  O García; M Martín; J Dopazo; J Arbiza; S Frabasile; J Russi; M Hortal; P Perez-Breña; I Martínez; B García-Barreno
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.